DEF 14A: Nortech Systems Seeks Shareholder Approval for Board Elections, Executive Pay, and Stock Incentive Plan Amendment

Sentiment:

Proxy Statement


Nortech Systems Incorporated has scheduled its annual virtual shareholder meeting for May 15, 2024, to vote on key proposals including the election of directors, executive compensation, and an amendment to the stock incentive plan.

Delay expectedMr. Lindeen filed a Form 4 late on February 13, 2024, regarding an option to purchase 2,000 shares of Common Stock granted on August 11, 2023.Mr. Peris filed a Form 3 on November 7, 2023, regarding his appointment as a director on October 27, 2023.David Graff filed a Form 4 late on May 16, 2023, regarding a restricted stock unit granted on May 11, 2023.

Summary

  • Nortech Systems Incorporated will hold its annual virtual shareholder meeting on May 15, 2024.
  • Shareholders will vote on the election of eight directors, an advisory vote on executive compensation (Say-on-Pay), and an amendment to the 2017 Stock Incentive Plan to increase the number of shares available for issuance from 675,000 to 775,000.
  • The meeting will also include a vote to ratify the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for fiscal year 2024.
  • The record date for determining shareholders eligible to vote is March 21, 2024.
  • The Board of Directors recommends voting in favor of all proposals.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, with a slightly positive tone due to the Board's recommendations to vote in favor of the proposals. The company is seeking to increase the number of shares available under the 2017 Stock Incentive Plan, which could help attract and retain employees.

Positives

  • The Board of Directors has determined that the positions of Chairperson of the Board and Chief Executive Officer should be held by different persons, enhancing oversight and independence.
  • The Audit Committee is comprised exclusively of independent directors.
  • The Compensation and Talent Committee and Nominating and Corporate Governance Committee will be comprised of four directors, three of whom are independent.
  • The company is seeking to increase the number of shares available under the 2017 Stock Incentive Plan, which could help attract and retain employees.

Negatives

  • Mr. Miller did not attend three meetings of the Board of Directors during the last fiscal year.
  • During 2023 until October 27, 2023, the Board was not comprised of a majority of independent directors.
  • Mr. Lindeen filed a Form 4 late on February 13, 2024, regarding an option to purchase 2,000 shares of Common Stock granted on August 11, 2023.
  • Mr. Peris filed a Form 3 on November 7, 2023, regarding his appointment as a director on October 27, 2023.
  • David Graff filed a Form 4 late on May 16, 2023, regarding a restricted stock unit granted on May 11, 2023.

Risks

  • The Company is a controlled company, which means it is not required to comply with certain NASDAQ rules regarding independent directors and committees.
  • There can be no assurances that Marpe Technologies medical device operations will be commercially successful.
  • There can be no assurances that Marpe Technologies will be successful in raising additional funds to finance its operations.
  • The Company may not recover the value of services provided to Marpe if not paid when the services are provided.

Future Outlook

The management does not know of any other matters that may be presented for consideration at the virtual annual meeting of shareholders. If any other matters are properly presented at the meeting, the persons named in the accompanying proxy will vote upon them in accordance with their best judgment.

Management Comments

  • The Board believes that the leadership structure of having separate Chairperson and CEO enhances the Board's oversight and independence from management.
  • The Board and management of the Company are committed to the quality, integrity and transparency of the Company's financial reports.

Industry Context

This document is a standard proxy statement, which is a common requirement for publicly traded companies to solicit shareholder votes on important matters. The proposals being voted on are typical for annual shareholder meetings.

Comparison to Industry Standards

  • The structure of the board and its committees aligns with common corporate governance practices for publicly traded companies.
  • The compensation structure for executive officers appears to be in line with industry standards, with a mix of cash and equity-based compensation.
  • The appointment of an independent registered public accounting firm is a standard practice for publicly traded companies to ensure the integrity of their financial reporting.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerAlan NordstromAndrew D. C. LaFrenceDecember 2023New employment agreement

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to 2017 Stock Incentive PlanIncreasing the shares of Common Stock reserved for issuance from 675,000 to 775,000.Upon approval by shareholders and the Board of DirectorsAims to attract, retain, and motivate employees, consultants, and directors.

Related Party Transactions

  • David Kunin, our Chairman, is a minority owner of Abilitech Medical, Inc.
  • Abilitech paid the Company $0 and $247 in the years ended December 31, 2023 and 2022, respectively, for delivery of medical products.
  • As of December 31, 2023, we have fully reserved our accounts receivable and inventory, aggregating $226, related to Abilitech.
  • David Kunin, our Chairman, is a minority owner (less than 10%) of Marpe Technologies, LTD.
  • The Company worked with Marpe Technologies to apply for a grant from the Israel-United States Binational Industrial Research and Development Foundation, a legal entity created by Agreement between the Government of the State of Israel and the Government of the United States of America (BIRD Foundation).
  • The parties were successful in receiving approval for a $1,000 conditional grant.
  • During the twelve months ended December 31, 2023 and 2022, we recognized net sales to Marpe Technologies of $163 and $440, respectively.
  • As of December 31, 2023, we have recorded an unbilled receivable of $39 related to expected reimbursement from the BIRD Foundation and have outstanding accounts receivable of $20.

Stakeholder Impact

  • Shareholders will have the opportunity to vote on key decisions affecting the Company's governance and executive compensation.
  • Employees may be affected by the proposed amendment to the stock incentive plan, which could provide them with additional equity-based compensation opportunities.
  • The ratification of the independent auditor is important for maintaining investor confidence in the Company's financial reporting.

Next Steps

  • Shareholders should review the proxy materials and vote on the proposals.
  • The Company will hold its Annual Meeting of Shareholders on May 15, 2024.
  • The Board of Directors will consider the outcome of the advisory vote on executive compensation.

Key Dates

DateDescription
2017-05Shareholders approved the adoption of the Nortech Systems Incorporated 2017 Stock Incentive Plan.
2019-05Shareholders approved an amendment to the Plan increasing the shares reserved for issuance from 350,000 to 400,000.
2022-02-27Company entered into an Employment Agreement with Jay D. Miller.
2022-05Shareholders approved an amendment to the Plan increasing the shares reserved for issuance from 400,000 to 575,000.
2023-05Shareholders approved an amendment to the Plan increasing the shares reserved for issuance from 575,000 to 675,000.
2023-05-12The Companys 2023 annual meeting was held.
2023-05-28David Graff passed away.
2023-12-01Andrew D. C. LaFrence commenced employment with the Company.
2023-12-03Mr. LaFrence was issued a non-qualified stock option for 40,000 shares of common stock.
2023-12-31End of fiscal year.
2024-01The Company received a payment of $28 from Abilitech for partial payment of previously fully reserved accounts receivable balances.
2024-03-12Committee memberships listed as of this date.
2024-03-13Board Diversity Matrix as of this date.
2024-03-21Record date for determining shareholders eligible to vote at the annual meeting.
2024-04-02Date of the proxy statement.
2024-05-14Shareholders of record may vote electronically until 11:59 p.m.
2024-05-15Annual Meeting of Shareholders.
2024-12-03Shareholder proposals and director nominations must be received on or before this date for the 2025 annual meeting.
2025-02-16Notices must be received on or before this date for an item of business to be considered at the 2025 annual shareholders meeting.

Keywords

proxy statement, annual meeting, board of directors, executive compensation, stock incentive plan, independent auditor, shareholders, directors, governance, Nortech Systems

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.